These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 5139650)

  • 21. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O
    Lakartidningen; 1972 Jun; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 23. [The treatment of Parkinson's disease with L-dopa].
    Dalle Ore G; Bricolo A; Robotti E; Bazzan A; Mazza C
    Policlinico Prat; 1970 Apr; 77(16):509-24. PubMed ID: 5443873
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract]   [Full Text] [Related]  

  • 25. [L-dopa in the treatment of Parkinson's disease. Preliminary report].
    Poch GF
    Prensa Med Argent; 1969 Oct; 56(34):1629-32. PubMed ID: 5405572
    [No Abstract]   [Full Text] [Related]  

  • 26. [L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].
    Lakke JP; Nienhuis RJ; Meyer R; Zwols F; Schut T
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2180-4. PubMed ID: 4639072
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of Parkinson's syndrome with L-dopa only and in combination with a decarboxylase inhibitor. A comparison].
    Feise G; Paal G
    Nervenarzt; 1974 Mar; 45(3):126-32. PubMed ID: 4832035
    [No Abstract]   [Full Text] [Related]  

  • 28. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 29. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA; De la Herrán J
    Rev Clin Esp; 1970 Dec; 119(6):555-62. PubMed ID: 5509794
    [No Abstract]   [Full Text] [Related]  

  • 30. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases].
    Herskovits E; Matera R; Gacitua EF
    Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629
    [No Abstract]   [Full Text] [Related]  

  • 31. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].
    Tissot R; Bartholini G; Constantinidis J; Eisenring JJ; Geissbühler F; Yanniotis G; de Ajuriaguerra J
    Schweiz Med Wochenschr; 1973 Oct; 103(42):1466-74. PubMed ID: 4750149
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract]   [Full Text] [Related]  

  • 35. L-dopa therapy in Parkinson's disease.
    Murray TJ
    N S Med Bull; 1972 Jun; 51(3):67-70. PubMed ID: 4504954
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of Parkinson's disease with L-dopa therapy.
    Tyler E
    Can Nurse; 1971 Apr; 67(4):41-2. PubMed ID: 5549360
    [No Abstract]   [Full Text] [Related]  

  • 37. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA; Campanella G
    Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease.
    Van Woert MH
    Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of L-dopa therapy in Parkinson's disease.
    Mones RJ; Elizan TS; Siegel GJ
    N Y State J Med; 1970 Sep; 70(18):2309-18. PubMed ID: 5272106
    [No Abstract]   [Full Text] [Related]  

  • 40. L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University).
    Gutmann L; Martin JD; Gutrecht JA
    W V Med J; 1970 Apr; 66(4):109-11. PubMed ID: 5264660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.